Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesDiseases and Disorders of the Nervous SystemDRG 103-headaches-without-mcc
    Ask Trek AI about this page

    Headaches without Major Complication or Comorbidity: Inpatient Reimbursement Overview

    DRG 103 groups inpatient admissions for headache without Major Complication or Comorbidity, addressing low-acuity headache diagnoses that do not drive high resource use. Accurate classification into this Diagnosis-Related Group matters for inpatient reimbursement because it determines the bundled Medicare payment for the episode of care.

    Customize your policy alerts

    Sign up for drg 103 policy alerts

    Get alerted when payer policies referencing 103 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 103 Overview

    DRG 103 covers hospital inpatient admissions for primary diagnoses of headache when no Major Complication or Comorbidity and no Complication or Comorbidity are present. This category typically includes conditions such as primary headache disorders and acute headache presentations that do not require major procedures or intensive resource use. It matters for Medicare payment because it groups like clinical cases to determine the bundled payment amount for the inpatient stay. Understanding this classification helps clarify expected reimbursement levels for low-acuity headache admissions.

    Table of contents

    Progress1 / 5

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    National Payment Rates

    Across commercial payers the observed rate range runs from about $370 up to $28K, with mean values spanning roughly $7.8K to $14K depending on payer. The widest spread is seen between BCBS’s minimums and Anthem’s maximums, producing the largest overall dispersion among payers. See the table and chart below for payer-level detail.

    The CMS 2023 data represent national Medicare FFS inpatient payments published in the CMS Provider Utilization and Payment Data program. The table below shows average total payment, average submitted covered charges, average Medicare payment amount, and total discharges for DRG 103 in 2023.

    Average Total PaymentAverage Submitted ChargesAverage Medicare PaymentTotal Discharges
    $8.8K$46K$5.8K6.4K

    Patient Population

    The DRG 103 population skews toward a mixed-age cohort with meaningful representation from both Medicare (age 65+) and working-age commercial enrollees. Medicare beneficiaries constitute a substantial portion of inpatient discharges reported in CMS data, while private/commercial payers (e.g., Aetna, BCBS, Cigna, Anthem) cover a sizable share of non-Medicare patients. Overall, the payer mix reflects both Medicare-age and working-age patients rather than being exclusive to one group.

    State Payment Rates

    State: Alaska1 / 49

    Alaska Benchmarks

    Payer rates for DRG 103 in Alaska cluster tightly for Anthem and Blue Cross Blue Shield at $13K, while Cigna presents a wider range with a mean of $20K and a max of $34K, producing the state-level span from $13K to $34K. This results in a notable deviation from national averages where Cigna’s Alaska mean exceeds typical national medians. See the table and chart below for the payer-level detail.

    Key Insights for Alaska

    • Anthem is the highest paying payer in Alaska at $13K, while Blue Cross Blue Shield is tied at the lowest reported rate of $13K.
    • Cigna shows the widest spread in Alaska with a mean of $20K and a max of $34K, a meaningful premium above national medians for similar payers.

    Clinical Trials

    • Acute emergency management trials evaluating rapid-acting therapies and protocols for severe primary headache presentations (including migraine with prominent nausea or intractable pain) that present to the emergency department. These studies enroll adults who are admitted under DRG 103 for acute headache without major comorbid conditions and compare time-to-pain-relief, need for rescue medication, and short-term disposition (observation versus discharge). Results inform emergency care pathways, reduce length of stay and resource utilization, and are directly relevant to hospital providers and payers focused on efficient, guideline-concordant acute management.
    • Comparative effectiveness studies of outpatient preventive strategies and care pathways initiated during hospitalization for recurrent headache disorders. These trials enroll patients admitted with disabling primary headache who have frequent prior attacks but no major complicating diagnoses, randomizing to different preventive regimens or integrated care models (e.g., neurology follow-up plus structured education versus usual care). Findings are important for determining which post-discharge interventions reduce readmissions, subsequent ED visits, and overall costs for the DRG cohort while improving functional outcomes.
    • Health services and outcomes research assessing disposition, resource use, and patient-reported outcomes for hospitalized patients with headache without MCC, including risk prediction and care coordination interventions. These observational and implementation studies use real-world hospital data to identify predictors of prolonged stay, return visits, and work/activity impairment, and to evaluate care coordination efforts (timely specialist consults, standardized order sets). Payers and hospital administrators use this evidence to target interventions that lower unnecessary admissions and optimize reimbursement and quality metrics for this DRG.

    Related Codes

    020-INTRACRANIAL-VASCULAR-PROCEDURES-WITH-PRINCIPAL-DIAGNOSIS-HEMORRHAGE-WITH-MCC

    Intracranial Vascular Procedures with Principal Diagnosis Hemorrhage with MCC: Inpatient Reimbursement Overview

    021-INTRACRANIAL-VASCULAR-PROCEDURES-WITH-PRINCIPAL-DIAGNOSIS-HEMORRHAGE-WITH-CC

    Intracranial Vascular Procedures with Principal Diagnosis Hemorrhage with CC: Inpatient Reimbursement Overview

    022-INTRACRANIAL-VASCULAR-PROCEDURES-WITH-PRINCIPAL-DIAGNOSIS-HEMORRHAGE-WITHOUT-CC-MCC

    Intracranial Vascular Procedures with Principal Diagnosis Hemorrhage without CC/MCC: Inpatient Reimbursement Overview

    023-CRANIOTOMY-WITH-MAJOR-DEVICE-IMPLANT-OR-ACUTE-COMPLEX-CNS-PRINCIPAL-DIAGNOSIS-WITH-MCC-OR-ANTINEOPLASTIC-IMPLANT-OR-EPILEPSY-WITH-NEUROSTIMULATOR

    Craniotomy with Major Device Implant or Complex CNS DRG 023: Inpatient Reimbursement Overview

    024-CRANIOTOMY-WITH-MAJOR-DEVICE-IMPLANT-OR-ACUTE-COMPLEX-CNS-PRINCIPAL-DIAGNOSIS-WITHOUT-MCC

    Craniotomy with Major Device Implant or Acute Complex CNS Principal Diagnosis without MCC: Inpatient Reimbursement Overview

    025-CRANIOTOMY-AND-ENDOVASCULAR-INTRACRANIAL-PROCEDURES-WITH-MCC

    Craniotomy and Endovascular Intracranial Procedures with MCC: Inpatient Reimbursement Overview

    026-CRANIOTOMY-AND-ENDOVASCULAR-INTRACRANIAL-PROCEDURES-WITH-CC

    Craniotomy and Endovascular Intracranial Procedures with CC: Inpatient Reimbursement Overview

    027-CRANIOTOMY-AND-ENDOVASCULAR-INTRACRANIAL-PROCEDURES-WITHOUT-CC-MCC

    Craniotomy and Endovascular Intracranial Procedures without CC/MCC: Inpatient Reimbursement Overview

    028-SPINAL-PROCEDURES-WITH-MCC

    Spinal Procedures with MCC: Inpatient Reimbursement Overview

    029-SPINAL-PROCEDURES-WITH-CC-OR-SPINAL-NEUROSTIMULATORS

    Spinal Procedures with CC or Spinal Neurostimulators: Inpatient Reimbursement Overview

    Showing 1–10 of 71

    • More pages

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

    Mean Rates by Payer — National — DRG 103
    Mean Rates by Payer — Alaska — DRG 103